Shares of Elan (ELN +3.5%) gain after a weekend report speculates that the Irish company's move...

|About: Elan Corporation, plc (ELN)|By:, SA News Editor

Shares of Elan (ELN +3.5%) gain after a weekend report speculates that the Irish company's move to merge its drug technologies business with Alkermes (ALKS) leaves it as a pure neuroscience play that might entice takeover interest. "With virtually no debt and an attractive drug portfolio, Elan is a sitting duck for one of the big boys," the report says.